Product image of Trodelvy (Sacituzumab Govitecan) supplied by GNH India

Trodelvy

Active Ingredient:
Sacituzumab Govitecan
Origin:
EU

Trodelvy (Sacituzumab Govitecan)

Trodelvy (sacituzumab govitecan) is an intravenous therapy for metastatic breast cancer. This targeted treatment delivers chemotherapy directly to cancer cells. It is prescribed after prior therapies have been tried. Always consult a healthcare provider for suitability.

Manufacturer / TM Owner

Gilead Sciences Ireland Unlimited Company

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Trodelvy is used to treat metastatic triple-negative breast cancer in adults. It may be prescribed when cancer has spread beyond the breast or lymph nodes. This medication is designed for patients who have already received at least two prior therapies for metastatic disease. It belongs to a class of drugs known as antibody-drug conjugates.

Side Effects

  • Trodelvy works by targeting cancer cells and delivering chemotherapy directly to them. Patients may experience side effects such as nausea, fatigue, or hair loss. These effects vary by individual and should be monitored by a healthcare professional. Regular check-ups help manage any treatment-related concerns.

Precautions & Warnings

  • Trodelvy is administered by healthcare providers in a clinical setting. Patients should report any unusual symptoms, such as severe diarrhea or infections, immediately. Blood tests are often required to monitor for side effects like low blood cell counts. Avoid close contact with people who are sick during treatment.

Avoid Interactions

  • Trodelvy may interact with other medications, including strong CYP3A4 inhibitors or inducers. Live vaccines should be avoided during treatment. Inform your doctor about all prescription, over-the-counter, and herbal products you are using. Alcohol and certain supplements may also interact with this therapy.

References

Frequently Asked Questions

Trodelvy is used to treat metastatic triple-negative breast cancer in adults who have received prior therapies.

Trodelvy is given as an intravenous infusion by a healthcare professional in a clinical setting.

Common side effects may include nausea, fatigue, diarrhea, and hair loss. These should be discussed with a healthcare provider.

Live vaccines should be avoided during treatment with Trodelvy. Consult your doctor before receiving any vaccines.

Trodelvy is an antibody-drug conjugate, which combines targeted therapy with chemotherapy to treat cancer cells.

Published by GNH India Pharmaceuticals Limited

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Sacituzumab Govitecan

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT